Jazz Pharmaceuticals
JAZZ
#2113
Rank
C$10.88 B
Marketcap
$180.11
Share price
0.63%
Change (1 day)
5.42%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): C$0.53 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are C$3.99 Billion. In 2023 the company made an earning of C$0.42 Billion, an increase over its 2022 earnings that were of -C$0.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.53 B25.74%
2023 C$0.42 B-179.92%
2022 -C$0.54 Billion230.37%
2021 -C$0.17 Billion-141.02%
2020 C$0.39 B-39.45%
2019 C$0.65 B-14.2%
2018 C$0.76 B20.03%
2017 C$0.63 B-17.15%
2016 C$0.76 B22.14%
2015 C$0.62 B187.64%
2014 C$0.21 B-50.79%
2013 C$0.44 B73.63%
2012 C$0.25 B41.69%
2011 C$0.18 B116.61%
2010 C$83.23 M262.77%
2009 C$22.94 M-111.33%
2008 -C$0.21 Billion1.31%
2007 -C$0.2 Billion77.8%
2006 -C$0.12 Billion36.59%
2005 -C$82.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$3.45 Billion-699.99%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$3.01 B 425.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.33 B 3,093.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$0.60 B 5.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel